U.S. v. ATROPINE SULFATE 1.0 MG. (ARTICLE OF DRUG)

No. 87-1392.

843 F.2d 860 (1988)

UNITED STATES of America, Plaintiff-Appellee, v. ATROPINE SULFATE 1.0 MG. (ARTICLE OF DRUG) DEY-DOSE, Defendant, and Dey Laboratories, Inc., Claimant-Appellant.

United States Court of Appeals, Fifth Circuit.

May 3, 1988.


Attorney(s) appearing for the Case

Harold Hoffman, Cynthia Hollingsworth, Dallas, Tex., and Marc H. Bozeman, Los Angeles, Cal., for claimant-appellant.

Lawrence G. McDade, Washington, D.C., for plaintiff-appellee.

Before WILLIAMS and HIGGINBOTHAM, Circuit Judges, and BROWN, District Judge.


PAUL N. BROWN, District Judge:

Dey Laboratories, Inc. (Dey) appeals from a summary judgment. In granting summary judgment the district court held that the atropine sulfate inhalant manufactured and marketed by Dey is a "new drug" under the Federal Food, Drug and Cosmetic Act, 21 U.S.C. §§ 301-392 (the Act). The district court was correct in holding that as a matter of law "any consensus which may exist regarding the safety or efficacy of [Dey's] ASI is not...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases